Ayr Wellness Inc.

AYRWF · OTC
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Valuation
PEG Ratio0.00-0.00-0.030.02
FCF Yield29.23%-23.06%4.00%-4.90%
EV / EBITDA543.67-5.39190.4844.56
Quality
ROIC-3.19%-11.07%-1.76%-0.90%
Gross Margin30.58%31.46%37.62%40.20%
Cash Conversion Ratio-0.190.06-0.320.15
Growth
Revenue 3-Year CAGR-1.37%-0.14%0.86%2.67%
Free Cash Flow Growth147.05%-252.25%174.31%-2,918.39%
Safety
Net Debt / EBITDA525.71-4.93138.4631.55
Interest Coverage-1.41-6.67-0.86-0.38
Efficiency
Inventory Turnover0.680.690.600.60
Cash Conversion Cycle99.48104.54116.37121.92
Ayr Wellness Inc. (AYRWF) Financial Analysis - Quarterly Metrics | AlphaPilot | AlphaPilot